Filing Details
- Accession Number:
- 0001178913-22-000219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-24 16:17:47
- Reporting Period:
- 2022-01-20
- Accepted Time:
- 2022-01-24 16:17:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1638097 | Entera Bio Ltd. | ENTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1766208 | Phillip Schwartz | Kiryat Hadassah, Minrav Building, 5Th Floor Jerusalem L3 9112002 | President Of R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value Nis 0.0000769 Per Share | Acquisiton | 2022-01-20 | 10,000 | $2.53 | 607,410 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.49 to $2.56, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., anIsraeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the rangeset forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
